A groundbreaking interim report on a clinical trial being conducted in three Indian hospitals is showing that a combination treatment of an Ayurvedic Remedy called ‘Immunofree’ by Corival Life Sciences, and a Nutraceutical called ‘Reginmune’ by Biogetica has shown groundbreaking results against the present Govt SOP of conventional meds for coronavirus treatment.
The interim report shows that patients on the natural treatment are resolving most symptoms earlier than those on conventional medicines. Furthermore, numerous tests such as C reactive protein, Procalcitonin, D Dimer and RT-PCR for novel coronavirus are also showing 20 to 60% better improvement for the natural treatment, when compared to conventional treatment.
Numerous subjective endpoints such as body pain and fatigue are also leaning towards the natural treatment. Both Clinician’s Global Assessment of Symptoms and Subject’s Global Assessment of Symptoms clearly showed improvements on both arms showing more significant data in the Test group. 86.66% of patients on the natural protocol have tested corona negative on day 5 vs 60% of patients on the conventional treatments. Moreover, on the 10th day test, all patients were negative, which could help in keeping the hospitals less occupied.
This CTRI approved trial is being conducted on Moderate COVID-19 positive patients. What sets this trial apart is the fact that it is the only time where half the patients in the trial have been given only natural treatment, which is being compared against the conventional treatment in use in India for COVID-19 patients.